KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis

Lucas E. Cavallin, Qi Ma, Julian Naipauer, Sachin Gupta, Mani Kurian, Paola Locatelli, Paolo Romanelli, Mehrdad Nadji, Pascal Goldschmidt-Clermont, Enrique A Mesri

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Kaposi’s sarcoma (KS) herpesvirus (KSHV) causes KS, an angiogenic AIDS-associated spindle-cell neoplasm, by activating host oncogenic signaling cascades through autocrine and paracrine mechanisms. Tyrosine kinase receptor (RTK) proteomic arrays, identified PDGF receptor-alpha (PDGFRA) as the predominantly-activated RTK in KSHV-induced mouse KS-tumors. We show that: 1) KSHV lytic replication and the vGPCR can activate PDGFRA through upregulation of its ligands PDGFA/B, which increase c-myc, VEGF and KSHV gene expression in infected cells 2) KSHV infected spindle cells of most AIDS-KS lesions display robust phospho-PDGFRA staining 3) blocking PDGFRA-signaling with N-acetyl-cysteine, RTK-inhibitors Imatinib and Sunitinib, or dominant-negative PDGFRA inhibits tumorigenesis 4) PDGFRA D842V activating-mutation confers resistance to Imatinib in mouse-KS tumorigenesis. Our data show that KSHV usurps sarcomagenic PDGFRA signaling to drive KS. This and the fact that PDGFRA drives non-viral sarcomas highlights the importance for KSHV-induced ligand-mediated activation of PDGFRA in KS sarcomagenesis and shows that this oncogenic axis could be successfully blocked to impede KS tumor growth.

Original languageEnglish (US)
Article numbere1007175
JournalPLoS Pathogens
Volume14
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Platelet-Derived Growth Factor alpha Receptor
Herpesviridae
Kaposi's Sarcoma
Ligands
Carcinogenesis
Acquired Immunodeficiency Syndrome
Neoplasms
Receptor Protein-Tyrosine Kinases
Sarcoma
Proteomics
Vascular Endothelial Growth Factor A
Cysteine
Up-Regulation
Staining and Labeling
Gene Expression

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Molecular Biology
  • Genetics
  • Virology

Cite this

KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis. / Cavallin, Lucas E.; Ma, Qi; Naipauer, Julian; Gupta, Sachin; Kurian, Mani; Locatelli, Paola; Romanelli, Paolo; Nadji, Mehrdad; Goldschmidt-Clermont, Pascal; Mesri, Enrique A.

In: PLoS Pathogens, Vol. 14, No. 7, e1007175, 01.07.2018.

Research output: Contribution to journalArticle

Cavallin, LE, Ma, Q, Naipauer, J, Gupta, S, Kurian, M, Locatelli, P, Romanelli, P, Nadji, M, Goldschmidt-Clermont, P & Mesri, EA 2018, 'KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis', PLoS Pathogens, vol. 14, no. 7, e1007175. https://doi.org/10.1371/journal.ppat.1007175
Cavallin LE, Ma Q, Naipauer J, Gupta S, Kurian M, Locatelli P et al. KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis. PLoS Pathogens. 2018 Jul 1;14(7). e1007175. https://doi.org/10.1371/journal.ppat.1007175
Cavallin, Lucas E. ; Ma, Qi ; Naipauer, Julian ; Gupta, Sachin ; Kurian, Mani ; Locatelli, Paola ; Romanelli, Paolo ; Nadji, Mehrdad ; Goldschmidt-Clermont, Pascal ; Mesri, Enrique A. / KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis. In: PLoS Pathogens. 2018 ; Vol. 14, No. 7.
@article{8ec809fde1ca461bac8f660ec6e3e7c4,
title = "KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis",
abstract = "Kaposi’s sarcoma (KS) herpesvirus (KSHV) causes KS, an angiogenic AIDS-associated spindle-cell neoplasm, by activating host oncogenic signaling cascades through autocrine and paracrine mechanisms. Tyrosine kinase receptor (RTK) proteomic arrays, identified PDGF receptor-alpha (PDGFRA) as the predominantly-activated RTK in KSHV-induced mouse KS-tumors. We show that: 1) KSHV lytic replication and the vGPCR can activate PDGFRA through upregulation of its ligands PDGFA/B, which increase c-myc, VEGF and KSHV gene expression in infected cells 2) KSHV infected spindle cells of most AIDS-KS lesions display robust phospho-PDGFRA staining 3) blocking PDGFRA-signaling with N-acetyl-cysteine, RTK-inhibitors Imatinib and Sunitinib, or dominant-negative PDGFRA inhibits tumorigenesis 4) PDGFRA D842V activating-mutation confers resistance to Imatinib in mouse-KS tumorigenesis. Our data show that KSHV usurps sarcomagenic PDGFRA signaling to drive KS. This and the fact that PDGFRA drives non-viral sarcomas highlights the importance for KSHV-induced ligand-mediated activation of PDGFRA in KS sarcomagenesis and shows that this oncogenic axis could be successfully blocked to impede KS tumor growth.",
author = "Cavallin, {Lucas E.} and Qi Ma and Julian Naipauer and Sachin Gupta and Mani Kurian and Paola Locatelli and Paolo Romanelli and Mehrdad Nadji and Pascal Goldschmidt-Clermont and Mesri, {Enrique A}",
year = "2018",
month = "7",
day = "1",
doi = "10.1371/journal.ppat.1007175",
language = "English (US)",
volume = "14",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis

AU - Cavallin, Lucas E.

AU - Ma, Qi

AU - Naipauer, Julian

AU - Gupta, Sachin

AU - Kurian, Mani

AU - Locatelli, Paola

AU - Romanelli, Paolo

AU - Nadji, Mehrdad

AU - Goldschmidt-Clermont, Pascal

AU - Mesri, Enrique A

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Kaposi’s sarcoma (KS) herpesvirus (KSHV) causes KS, an angiogenic AIDS-associated spindle-cell neoplasm, by activating host oncogenic signaling cascades through autocrine and paracrine mechanisms. Tyrosine kinase receptor (RTK) proteomic arrays, identified PDGF receptor-alpha (PDGFRA) as the predominantly-activated RTK in KSHV-induced mouse KS-tumors. We show that: 1) KSHV lytic replication and the vGPCR can activate PDGFRA through upregulation of its ligands PDGFA/B, which increase c-myc, VEGF and KSHV gene expression in infected cells 2) KSHV infected spindle cells of most AIDS-KS lesions display robust phospho-PDGFRA staining 3) blocking PDGFRA-signaling with N-acetyl-cysteine, RTK-inhibitors Imatinib and Sunitinib, or dominant-negative PDGFRA inhibits tumorigenesis 4) PDGFRA D842V activating-mutation confers resistance to Imatinib in mouse-KS tumorigenesis. Our data show that KSHV usurps sarcomagenic PDGFRA signaling to drive KS. This and the fact that PDGFRA drives non-viral sarcomas highlights the importance for KSHV-induced ligand-mediated activation of PDGFRA in KS sarcomagenesis and shows that this oncogenic axis could be successfully blocked to impede KS tumor growth.

AB - Kaposi’s sarcoma (KS) herpesvirus (KSHV) causes KS, an angiogenic AIDS-associated spindle-cell neoplasm, by activating host oncogenic signaling cascades through autocrine and paracrine mechanisms. Tyrosine kinase receptor (RTK) proteomic arrays, identified PDGF receptor-alpha (PDGFRA) as the predominantly-activated RTK in KSHV-induced mouse KS-tumors. We show that: 1) KSHV lytic replication and the vGPCR can activate PDGFRA through upregulation of its ligands PDGFA/B, which increase c-myc, VEGF and KSHV gene expression in infected cells 2) KSHV infected spindle cells of most AIDS-KS lesions display robust phospho-PDGFRA staining 3) blocking PDGFRA-signaling with N-acetyl-cysteine, RTK-inhibitors Imatinib and Sunitinib, or dominant-negative PDGFRA inhibits tumorigenesis 4) PDGFRA D842V activating-mutation confers resistance to Imatinib in mouse-KS tumorigenesis. Our data show that KSHV usurps sarcomagenic PDGFRA signaling to drive KS. This and the fact that PDGFRA drives non-viral sarcomas highlights the importance for KSHV-induced ligand-mediated activation of PDGFRA in KS sarcomagenesis and shows that this oncogenic axis could be successfully blocked to impede KS tumor growth.

UR - http://www.scopus.com/inward/record.url?scp=85051071760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051071760&partnerID=8YFLogxK

U2 - 10.1371/journal.ppat.1007175

DO - 10.1371/journal.ppat.1007175

M3 - Article

C2 - 29985958

AN - SCOPUS:85051071760

VL - 14

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 7

M1 - e1007175

ER -